Targeting TLRs and the inflammasome in systemic sclerosis

Keyphrases

• Systemic Sclerosis 100%
• Inflammasome 100%
• Toll-like 100%
• NLRP3 Inflammasome 66%
• Fibrosis 66%
• Inflammation 33%
• Extracellular Matrix Protein 1 (ECM1) 33%
• Novel Therapeutics 33%
• Therapeutic Potential 33%
• Etiology 33%
• Autoimmune Disease 33%
• Curative Treatment 33%
• Receptor Signaling 33%
• Poor Prognosis 33%
• Innate Immune Response 33%
• Signaling Events 33%
• Protein Production 33%
• Cytokine Dysregulation 33%
• Excessive Extracellular Matrix 33%

Medicine and Dentistry

• Systemic Scleroderma 100%
• Toll Like Receptor 100%
• Inflammasome 100%
• Fibrosis 66%
• NLRP3 Inflammasome 66%
• Cytokine 33%
• Upregulation 33%
• Innate Immunity 33%
• Extracellular Matrix Protein 33%
• Vascular Disorder 33%
• Autoimmune Disease 33%

Immunology and Microbiology

• Systemic Scleroderma 100%
• Toll-Like Receptor 100%
• Inflammasome 100%
• NLRP3 Inflammasome 66%
• Innate Immune System 33%
• Matrix Protein 33%
• Autoimmune Disease 33%
• Upregulation 33%
• Extracellular Matrix 33%
• Cytokine 33%
• Vasculitis 33%